Trial of Cell Based Therapy for DMD

NCT06692426 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: MyoPAXon
DRUG: Tacrolimus

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]
[object Object]